Funding for this research was provided by:
Ministero della Salute ("Ricerca Corrente")
Bundesministerium für Bildung und Forschung (FTLDc O1GI1007A)
EU Joint Programme – Neurodegenerative Disease Research (SOPHIA (01ED1202A), BiomarkAPD (01ED1203F) and Prefrontals (01ED1512))
Received: 11 July 2019
Accepted: 21 November 2019
First Online: 31 December 2019
Ethics approval and consent to participate
: The study was conducted according to the revised Declaration of Helsinki and Good Clinical Practice guidelines. Informed consent was provided by study participants or their next of kin. The study protocol was approved by the ethics committees of “Area Vasta Emilia Centro” (approval number CE-AVEC: 18025, 113/2018/OSS/AUSLBO) and Ulm University (approval number 20/10).
: Not applicable.
: The authors declare that they have no competing interests.